AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2025 Issue 3; Ask the Editor
Encounter for Administration of Prophylactic Monoclonal Antibodies in Newborns for Prevention of Respiratory Syncytial Virus (RSV)
What is the correct diagnosis code assignment for an encounter for the administration of prophylactic long-acting monoclonal antibodies, such as Nirsevimab-alip (Beyfortus™), for respiratory syncytial virus (RSV)? ...
Subscribe or sign in to view the full article.
Article Overview
This article explains the diagnosis coding topic for prophylactic respiratory syncytial virus (RSV) immunotherapy in newborns, including encounters involving long-acting monoclonal antibodies. It is relevant to coders and billing staff working with preventive pediatric services and diagnosis assignment for RSV-related immunization/immunotherapy encounters.
Why This Topic Matters
Correct diagnosis coding for preventive RSV-related monoclonal antibody encounters supports accurate claim processing and documentation of prophylactic care in newborns.
What You Will Learn
- How the article frames prophylactic RSV immunotherapy encounters
- The general coding topic associated with newborn preventive monoclonal antibody administration
- Why this type of encounter matters for diagnosis assignment and claim documentation
- The broad clinical and administrative context for RSV prevention services
Who Should Read This
- Medical coders
- Coding auditors
- Billing staff
- Pediatric practice staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com